logo
Select company
Select metric
$ -77.77MWorking Capital
VS
Market
9
Sector
2
Industry
0
History
48
$ 0.24Close
$ 0.19 - $ 0.44 52-Week Range
Ticker Information

Ticker

NWBO

Company Name

NORTHWEST BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

NORTHWEST BIOTHERAPEUTICS INC - Working Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NWBO - Working Capital Historical data
DateCurrent AssetsCurrent LiabilitiesWorking Capital
6/30/2025$ 6.16M$ 83.92M$ -77.77M
3/31/2025$ 4.69M$ 83.06M$ -78.37M
12/31/2024$ 4.06M$ 68.27M$ -64.21M
9/30/2024$ 5.19M$ 59.56M$ -54.37M
6/30/2024$ 4.98M$ 56.17M$ -51.2M
3/31/2024$ 4.95M$ 62.44M$ -57.49M
12/31/2023$ 4.13M$ 45.2M$ -41.08M
9/30/2023$ 8.45M$ 49.22M$ -40.77M
6/30/2023$ 4.64M$ 39.92M$ -35.28M
3/31/2023$ 9.49M$ 44.71M$ -35.22M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NORTHWEST BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) Working Capital stands at $ -214.09M.
  • Over the past 5 years, NORTHWEST BIOTHERAPEUTICS INC's average Working Capital has been $ -133.72M.
  • The median Working Capital for NORTHWEST BIOTHERAPEUTICS INC during this period was $ -84.68M
  • NORTHWEST BIOTHERAPEUTICS INC reached its highest Working Capital over the past 5 years at $ -35.22M.
  • The lowest Working Capital recorded by NORTHWEST BIOTHERAPEUTICS INC in the same timeframe $ -366.91M

NORTHWEST BIOTHERAPEUTICS INC's Working Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Working Capital Benchmarks
CompanyWorking Capital
RNAC : CARTESIAN THERAPEUTICS INC $ 151.14MINBX : INHIBRX BIOSCIENCES INC $ 155.03MHUMA : HUMACYTE INC $ 30.64MABEO : ABEONA THERAPEUTICS INC $ 197.75MMREO : MEREO BIOPHARMA GROUP PLC $ 53.86MSEPN : SEPTERNA INC $ 319.01MCRDF : CARDIFF ONCOLOGY INC $ 57.03MCATX : PERSPECTIVE THERAPEUTICS INC $ 182.97MBTAI : BIOXCEL THERAPEUTICS INC $ -8.13MADVM : ADVERUM BIOTECHNOLOGIES INC $ 17.04M

Definition of Working Capital

[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for NORTHWEST BIOTHERAPEUTICS INC is calculated as follows: AssetsC [ $ 12.18M ] - LiabilitesC [ $ 226.28M ]
(=) Working Capital [ $ -214.09M ]

NWBO - Working Capital, Last 5 years

$ -366.91M

Minimum

Dec 31, 2020

$ -35.22M

Maximum

Mar 31, 2023

$ -133.72M

Average

$ -84.68M

Median

Working Capital Benchmark Analysis

The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.6M with a standard deviation of $ 173.49M.
The following table provides additional summary stats:
Working Capital in the Market:
filtered constituents2.78K
min$ -457.39M
max$ 607.04M
average$ 96.6M
median$ 32.21M
std$ 173.49M